Immunoreactivity of the 14F7 Mab (Raised against N-Glycolyl GM3 ganglioside) as a positive prognostic factor in non-small-cell lung cancer

Pathology Research International

Volumn 2012, Issue , 2012, Pages

  Blanco, Rancés ^a   Rengifo, Charles E ^b   Cedeño, Mercedes ^a   Frómeta, Milagros ^a   Rengifo, Enrique ^a   Carr, Adriana ^a  

^a CENTER OF MOLECULAR IMMUNOLOGY   (Cuba)

^b Hospital Manuel Fajardo   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866058213     PISSN: None     EISSN: 2042003X     Source Type: Journal    
DOI: 10.1155/2012/235418     Document Type: Article

References (47)

1. Kaira K., kkaira1970@yahoo.co.jp Oriuchi N., Sunaga N., Ishizuka T., Shimizu K., Yamamoto N., A systemic review of PET and biology in lung cancer. American Journal of Translational Research 2011 3 4 383 391
2. Barzi A., Pennell N. A., Targeting angiogenesis in non-small cell lung cancer: agents in practice and clinical development. European Journal of Clinical and Medical Oncology 2010 2 1 31 42 2-s2.0-77956276361
3. Blanchard E., Targeted agents in non small cell lung cancer. Cancer Therapy 2008 6 95 102
4. 3 ganglioside elicited in non-small cell lung cancer patients immunized with an anti-idiotype antibody. Journal of Immunology 2008 181 9 6625 6634 2-s2.0-58149456558
5. Zhang S., Cordon-Cardo C., Zhang H. S., Reuter V. E., Adluri S., Hamilton W. B., Lloyd K. O., Livingiston P. O., Selection of tumor antigens as targets for immune attack using immunohistochemistry: I. Focus on gangliosides. International Journal of Cancer 1997 73 1 42 49 10.1002/(SICI)1097- 0215(19970926)73:142::AID-IJC8>3.0.CO;2-1 (Pubitemid 27445989)
6. Higashi H., Nishi Y., Fukui Y., Tumor-associated expression of glycosphingolipid Hanganutziu-Deicher antigen in human cancers. Gann, The Japanese Journal of Cancer Research 1984 75 11 1025 1029 (Pubitemid 15221964)
7. Malykh Y. N., Schauer R., Shaw L., N-Glycolylneuraminic acid in human tumours. Biochimie 2001 83 7 623 634 2-s2.0-0034844959 10.1016/S0300-9084(01) 01303-7 (Pubitemid 32821226)
8. Tangvoranuntakul P., Gagneux P., Diaz S., Bardor M., Varki N., Varki A., Muchmore E., Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid. Proceedings of the National Academy of Sciences of the United States of America 2003 100 21 12045 12050 2-s2.0-0142059844 10.1073/pnas. 2131556100 (Pubitemid 37271512)
9. Bardor M., Nguyen D. H., Diaz S., Varki A., Mechanism of uptake and incorporation of the non-human sialic acid N-glycolylneuraminic acid into human cells. Journal of Biological Chemistry 2005 280 6 4228 4237 2-s2.0-14244266499 10.1074/jbc.M412040200 (Pubitemid 40288589)
10. Chou H. H., Takematsu H., Diaz S., Iber J., Nickerson E., Wright K. L., Muchmore E. A., Nelson D. L., Warren S. T., Varki A., A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence. Proceedings of the National Academy of Sciences of the United States of America 1998 95 20 11751 11756 2-s2.0-0032578387
11. 3 ganglioside recognized breast and melanoma tumors. Hybridoma 2000 19 3 241 247 2-s2.0-0033624355 10.1089/02724570050109639 (Pubitemid 30622625)
12. Vazquez A. M., Alfonso M., Lanne B., Karlsson K. A., Carr A., Barroso O., Fernandez L. E., Rengifo E., Lanio M. E., Alvarez C., Zeuthen J., Perez R., Generation of a murine monoclonal antibody specific for N-glycolylneuraminic acid-containing gangliosides that also recognizes sulfated glycolipids. Hybridoma 1995 14 6 551 556 2-s2.0-0029586061 (Pubitemid 26028517)
13. 3 expression and signal transducer and activator of transcription (STAT)-3 activation in relation to dendritic cell infiltration and microvessel density in non-small cell lung cancer. BMC Cancer 2009 9, article 180 2-s2.0-67650394884 10.1186/1471-2407-9-180
14. 3 ganglioside in epithelial malignant tumors from digestive system. ISRN Gastroenterology 2011 2011 8 10.5402/2011/645641 645641
15. Hedley D. W., Friedlander M. L., Taylor I. W., Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. Journal of Histochemistry and Cytochemistry 1983 31 11 1333 1335 (Pubitemid 14226962)
16. Buccheri G., Ferrigno D., Prognostic value of stage grouping and TNM descriptors in lung cancer. Chest 2000 117 5 1247 1255 2-s2.0-0034035234 (Pubitemid 30321575)
17. Lyons G., Quadrelli S., Chimondegy D., Iotti A., Silva C., Tumor size and survival in lung cancer, stage IA. Medicina 2008 68 1 23 30 2-s2.0-42049094197 (Pubitemid 351516411)
18. Perng R. P., Chen C. Y., Chang G. C., Hsia T. C., Hsu N. Y., Tsai Y. H., Tsai C. M., Yang C. H., Chen Y. M., Yu C. J., Lee J. J., Hsu H. S., Yu C. T., Kao E. L., Chiu C. H., Revisit of 1997 TNM staging systemSurvival analysis of 1112 lung cancer patients in Taiwan. Japanese Journal of Clinical Oncology 2007 37 1 9 15 2-s2.0-34447645694 10.1093/jjco/hyl119 (Pubitemid 47090718)
19. Qiu Y., Yang H., Chen H., Ge L., Xu X., Xiong X., He J., Detection of CEA mRNA, p53 and AE1/AE3 in haematoxylin-eosin-negative lymph nodes of early-stage non-small cell lung cancer may improve veracity of N staging and indicate prognosis. Japanese Journal of Clinical Oncology 2010 40 2 146 152 2-s2.0-77449133848 10.1093/jjco/hyp144 hyp144
20. 3 ganglioside in some benign and malignant skin neoplasms. ISRN Dermatology 2011 2011 8 848909
21. 3 ganglioside in some normal and malignant tissues from genitourinary system. ISRN Pathology 2011 2011 10 953803
22. 3 ganglioside in cancer progression: effect over CD4 expression on T cells. Cancer Immunology, Immunotherapy 2006 55 4 443 450 2-s2.0-30444446808 10.1007/s00262-005-0041-6 (Pubitemid 43076896)
23. + regulatory T cells function. International Immunology 2008 20 4 591 600 2-s2.0-41149148210 10.1093/intimm/dxn018 (Pubitemid 351426051)
24. 3 ganglioside in neuroectodermal tumors by immunohistochemistry: an attractive vaccine target for aggressive pediatric cancer. Clinical and Developmental Immunology 2011 2011 6 245181 10.1155/2011/245181
25. Tubiana M., Courdi A., Cell proliferation kinetics in human solid tumours: relation to probability of metastatic dissemination and long-term survival. Radiotherapy and Oncology 1989 15 1 18 (Pubitemid 19147615)
26. Ten Velde G. P. M., Schutte B., Vermeulen A., Volovics A., Reynders M. M. J., Blijham G. H., Flow cytometric analysis of DNA ploidy level in paraffin-embedded tissue of non-small-cell lung cancer. European Journal of Cancer and Clinical Oncology 1988 24 3 455 460 2-s2.0-0023931379 (Pubitemid 18071276)
27. 3 modulates tumor suppressor PTEN-mediated cell cycle progressionTranscriptional induction of p21WAF1 and p27kip1 by inhibition of PI-3K/AKT pathway. Glycobiology 2006 16 7 573 583 2-s2.0-33745587546 10.1093/glycob/cwj105 (Pubitemid 43985498)
28. Li D. M., Sun H., PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells. Proceedings of the National Academy of Sciences of the United States of America 1998 95 26 15406 15411 2-s2.0-0032431028 10.1073/pnas.95.26.15406 (Pubitemid 29018711)
29. Ludovini V., Pistola L., Gregorc V., Floriani I., Rulli E., Di Carlo L., Semeraro A., Daddi G., Darwish S., Stocchi L., Tofanetti F. R., Bellezza G., Sidoni A., Tognellini R., Crinò L., Tonato M., Biological markers and DNA flow cytometric analysis in radically resected patients with non-small cell lung cancer. A study of the perugia multidisciplinary team for thoracic tumors. Tumori 2008 94 3 398 405 2-s2.0-48249087719
30. Scursoni A. M., Galluzzo L., Camarero S., Pozzo N., Gabri M. R., De Acosta C. M., Vázquez A. M., Alonso D. F., De Davila M. T. G., Detection and characterization of N-glycolyated gangliosides in Wilms tumor by immunohistochemistry. Pediatric and Developmental Pathology 2010 13 1 18 23 2-s2.0-77949739944 10.2350/08-10-0544.1
31. Saber S., Salehian P., P53 and Ki67 biomarkers as prognostic factors of non small cell lung carcinoma. Acta Medica Iranica 2005 43 2 127 130 2-s2.0-26244452743 (Pubitemid 41414822)
32. Simony J., Pujol J. L., Radal M., Ursule E., Michel F. B., Pujol H., In situ evaluation of growth fraction determined by monoclonal antibody Ki-67 and ploidy in surgically resected non-small cell lung cancers. Cancer Research 1990 50 14 4382 4387 2-s2.0-0025277089 (Pubitemid 20225683)
33. Pence J. C., Kerns B. J. M., Dodge R. K., Iglehart J. D., Prognostic significance of the proliferation index in surgically resected non-small-cell lung cancer. Archives of Surgery 1993 128 12 1382 1390 2-s2.0-0027440644 (Pubitemid 23360034)
34. Choma D., Daurès J. P., Quantin X., Pujol J. L., Aneuploidy and prognosis of non-small-cell lung cancer: a meta-analysis of published data. British Journal of Cancer 2001 85 1 14 22 2-s2.0-0035816267 10.1054/bjoc.2001. 1892 (Pubitemid 32695710)
35. Park S. Y., Lee H.-S., thoracic@ncc.re.kr Jang H.-J., Lee G. K., Chung K. Y., Zo J. I., Tumor necrosis as a prognostic factor for stage IA non-small cell lung cancer. Annals of Thoracic Surgery 2011 91 6 1668 1673 10.1016/j.athoracsur.2010.12.028
36. Swinson D. E. B., Jones J. L., Richardson D., Cox G., Edwards J. G., O'Byrne K. J., Tumour necrosis is an independent prognostic marker in non-small cell lung cancer: correlation with biological variables. Lung Cancer 2002 37 3 235 240 2-s2.0-0036755102 10.1016/S0169-5002(02)00172-1 (Pubitemid 35291153)
37. Yin J., Hashimoto A., Izawa M., Miyazaki K., Chen G. Y., Takematsu H., Kozutsumi Y., Suzuki A., Furuhata K., Cheng F. L., Lin C. H., Sato C., Kitajima K., Kannagi R., Hypoxic culture induces expression of sialin, a sialic acid transporter, and cancer-associated gangliosides containing non-human sialic acid on human cancer cells. Cancer Research 2006 66 6 2937 2945 2-s2.0-33645532616 10.1158/0008-5472.CAN-05-2615
38. Sonnino S., Mauri L., Chigorno V., Prinetti A., Gangliosides as components of lipid membrane domains. Glycobiology 2007 17 1 1 13 2-s2.0-33845596453 10.1093/glycob/cwl052 (Pubitemid 44932810)
39. Silveira E. Souza A. M. M., Trindade E. S., Jamur M. C., Oliver C., Gangliosides are important for the preservation of the structure and organization of RBL-2H3 mast cells. Journal of Histochemistry and Cytochemistry 2010 58 1 83 93 2-s2.0-74049154774 10.1369/jhc.2009.954776
40. Higashi H., Naiki M., Matuo S., Okouchi K., Antigen of serum sickness type of heterophile antibodies in human sera: identification as gangliosides with N-glycolylneuraminic acid. Biochemical and Biophysical Research Communications 1977 79 2 388 395 2-s2.0-0017665490 (Pubitemid 8239124)
41. Schlenzka W., Shaw L., Kelm S., Schmidt C. L., Bill E., Trautwein A. X., Lottspeich F., Schauer R., CMP-N-acetylneuraminic acid hydroxylase: the first cytosolic Rieske iron-sulphur protein to be described in Eukarya. FEBS Letters 1996 385 3 197 200 2-s2.0-0029941677 10.1016/0014-5793(96)00384-5 (Pubitemid 26169815)
42. Marquina G., Waki H., Fernandez L. E., Kon K., Carr A., Valiente O., Perez R., Ando S., Gangliosides expressed in human breast cancer. Cancer Research 1996 56 22 5165 5171 2-s2.0-0029803151 (Pubitemid 26383031)
43. Meivar-Levy I., Sabanay H., Bershadsky A. D., Futerman A. H., The role of sphingolipids in the maintenance of fibroblast morphology. Journal of Biological Chemistry 1997 17 1558 1564
44. 3 clusters in the cell membrane depends on the intact actin cytoskeleton. Biochimica et Biophysica Acta 2009 1791 5 388 396 2-s2.0-64749090227 10.1016/j.bbalip.2009.01.008
45. Roque-Navarro L., Chakrabandhu K., De León J., Rodríguez S., Toledo C., Carr A., De Acosta C. M., Hueber A. O., Pérez R., Anti-ganglioside antibody-induced tumor cell death by loss of membrane integrity. Molecular Cancer Therapeutics 2008 7 7 2033 2041 2-s2.0-51049099189 10.1158/1535-7163.MCT-08-0222
46. Chou J., Lin Y. C., Kim J., You L., Xu Z., He B., Jablons D. M., Nasopharyngeal carcinomaReview of the molecular mechanisms of tumorigenesis. Head and Neck 2008 30 7 946 963 2-s2.0-47549106723 10.1002/hed.20833 (Pubitemid 352008957)
47. Carr A., Mesa C., Arango M. D. C., Vázquez A. M., Fernández L. E., In vivo and in vitro anti-tumor effect of 14F7 monoclonal antibody. Hybridoma and Hybridomics 2002 21 6 463 468 2-s2.0-0037716989 (Pubitemid 36575465)